| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 02/28/2007 | EP1757583A1 Process for producing cyclic n-hydroxyimide compound |
| 02/28/2007 | EP1756063A1 Amido compounds and their use as pharmaceuticals |
| 02/28/2007 | EP1755593A1 Naphthaline derivatives useful as histamine-3-receptor ligands |
| 02/28/2007 | CN1922137A Protease inhibitors |
| 02/27/2007 | US7183282 N'-methyl-2-[(p-fluorophenyl)-4-oxo-butyl]piperazino[1,2-fg]gamma-carboline; N'-methyl-2-[p-fluorophenoxypropyl]piperazino[1,2-fg]gamma-carboline; serotonin modulators; sleep disorders; central nervous system disorders |
| 02/27/2007 | US7183272 Crystal forms of oxcarbazepine and processes for their preparation |
| 02/27/2007 | US7183271 Vasopressin active materials; antidiabetic agents; diuretics; bioavailability |
| 02/27/2007 | US7183270 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/27/2007 | US7183059 Selecting desired synthetic precursors having defined stereochemical relationships, reacting precursors to obtain compound having specific stereochemistry, repeating selecting and reacting until desired library is obtained |
| 02/22/2007 | WO2007020190A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/22/2007 | US20070043026 Dopamine receptor modulators as antipsychotic agents |
| 02/22/2007 | CA2619223A1 Fluoro substituted 2-oxo azepan derivatives |
| 02/21/2007 | EP1754707A2 Multicyclic compounds and their use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 02/21/2007 | EP1511727B1 Aromatic sulfones and their medical use |
| 02/20/2007 | CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037789 4-chloro-N-((R)-5,5-difluoro-2-oxo-azepan-3-yl)-N-[2-fluoro-4-(2H-[1,2,4]triazol-3-yl)-benzyl]-benzenesulfonamide; gamma -secretase inhibitor; neurodegenerative diseases; Alzheimer's disease; anticarcinogenic agent; cervical carcinomas and breast carcinomas and malignancies of the hematotic system |
| 02/14/2007 | EP1751163A2 Compounds having affinity for dopamine d3 receptor and uses thereof |
| 02/14/2007 | EP1751108A1 Adamantyl-acetamide derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176198 1H-pyrazole and 1H-pyrrole-azabicyclic compounds for the treatment of disease |
| 02/13/2007 | US7176197 Process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/08/2007 | WO2006110477A3 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 02/08/2007 | US20070032647 Novel process for preparation of 10-oxo-10, 11-dihydro-5h-dibenz [b,f] azepine-5-carbox- amide (oxcarbazepine) via intermediate, 10-methoxy-5h-debenz[b,f] azepine-5-carbonyl- chloride |
| 02/08/2007 | US20070032541 monocyte chemotactic proteins (MCP)-1 receptor antagonist or agonist; 2-{1-[(1,2-cis)-2-(4-Methylsulfanyl-benzoylamino)-cyclohexyl]-2-oxo-pyrrolidin-3-ylcarbamoyl}-4-trifluoromethyl-phenyl)-carbamic acid tert-butyl ester; antiinflammatory agent, antiallergen; asthma, rheumatoid arthritis, atherosclerosis |
| 02/07/2007 | EP1748988A1 A process for the preparation of iminostilbene derivatives |
| 02/07/2007 | EP1606255A4 Cyclic derivatives as modulators of chemokine receptor activity |
| 02/07/2007 | CN1910175A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin |
| 02/07/2007 | CN1910149A Bronchorelaxing compounds |
| 02/07/2007 | CN1910141A Diamino alcohols and their use as renin inhibitors |
| 02/06/2007 | US7173025 Compounds for use as anticoagulants for treatment of arteries in brains and factor x inhibitors |
| 02/06/2007 | US7173023 Novel benzazepine derivatives as enzyme inhibitors of monoamine oxidase for disease treatment |
| 02/01/2007 | WO2007013697A1 AXIS-ASYMMETRIC OPTICALLY ACTIVE QUATERNARY AMMONIUM SALT, AND PROCESS FOR PRODUCTION OF α-AMINO ACID OR DERIVATIVE THEREOF USING THE QUATERNARY AMMONIUM SALT |
| 02/01/2007 | WO2007012793A1 Asymmetric catalytic reduction of oxcarbazepine |
| 02/01/2007 | US20070027132 Containing a benzodiazepine ring; 2-Cyclopentylmethyl-3(S)-hydroxyl-1-oxo-5-phenylpentyl)amino-1-methyl-5-(4-fluoro-phenyl)-2,3-dihydro-1H-1,5-benzodiazepin-2-one; Alzheimer's disease and Down's Syndrome; prevent the formation of neurological deposits of amyloid protein |
| 02/01/2007 | CA2616984A1 Asymmetric catalytic reduction of oxcarbazepine |
| 01/31/2007 | CN1906170A 7-[4-(4-chlorobenzyloxy) benzenesulfonyl]-8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-3-benzazepinium maleate or tosylate as antipsychotics |
| 01/30/2007 | US7169772 Vasopressin active material; antidiabetic agents; diuretics; bioavailability |
| 01/30/2007 | CA2226886C N-(4-substituted-benzyl)-2-aminolactam derivatives |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/25/2007 | US20070021604 To be used as acidic catalysts |
| 01/25/2007 | US20070021404 Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/23/2007 | US7166720 Process for the preparation of α-aminosubstituted carboxylic acid amides |
| 01/23/2007 | US7166587 Gamma -secretase inhibitors; for treatment of Alzheimer's disease; e.g 2,3-difluoro-benzyl)-carbamic acid (S)-1-(5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-ylcarbamoyl)-ethyl ester |
| 01/18/2007 | WO2006017443A3 Aryl-amino substituted pyrrolopyrimidine multi-kinase inhibiting compounds |
| 01/17/2007 | EP1341531B1 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 01/17/2007 | CN1897953A Anti-inflammatory agents |
| 01/17/2007 | CN1896056A Production of epsilon-caprolactam |
| 01/16/2007 | US7164027 Aralkyl ester soft drugs |
| 01/11/2007 | WO2007004959A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 01/11/2007 | WO2007003934A2 17beta-hydr0xyster0id dehydrogenase type 3 (17beta-hsd3 ) inhibitors |
| 01/11/2007 | WO2006020959A3 Substituted benzofused heterocycles |
| 01/11/2007 | US20070010509 Cycloamine ccr5 receptor antagonists |
| 01/10/2007 | CN1894217A Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 01/09/2007 | US7160875 Malonamide derivatives |
| 01/04/2007 | WO2006047479A3 C-fms kinase inhibitors |
| 01/04/2007 | US20070003788 Organic electroluminescence device |
| 01/03/2007 | EP1613602B1 Alkylated iminodibenzyls as antioxidants |
| 01/02/2007 | US7157596 Inhibitors of serine protease activity of matriptase or MTSP1 |
| 12/28/2006 | US20060293518 Proccess for the preparation of phenylcarbamates |
| 12/27/2006 | EP1736467A1 Novel sulfonamide derivative |
| 12/27/2006 | EP1735299A1 Tertrahydrobenzazepines as histamine h3 receptor ligands |
| 12/27/2006 | EP1735270A1 Diamino alcohols and their use as renin inhibitors |
| 12/27/2006 | EP1385826B1 Method for preparation of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/26/2006 | US7153958 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 12/26/2006 | US7153847 Dipeptide-substituted benzo- and dibenzocaprolactams, which inhibit beta -amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease |
| 12/26/2006 | US7153846 2-(3,4,5-trihydroxy-2-methoxy-8-methyl-6-decenoylamino)-E-caprolactams that may be esterified; treatment of cancer, especially cancers of the breast, colon, lung, and prostate and glioblastomas and leukemia |
| 12/21/2006 | WO2006134384A1 Anti-inflammatory agents |
| 12/21/2006 | US20060287402 Cathepsin inhibitors |
| 12/21/2006 | US20060287298 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 12/21/2006 | US20060287294 Aspartyl protease inhibitors |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | CA2612217A1 Anti-inflammatory agents |
| 12/20/2006 | EP1636178B1 Method for making caprolactam |
| 12/20/2006 | EP1474152B1 Orodispersible pharmaceutical composition comprising ivabradine |
| 12/20/2006 | EP1288198B1 Process for the production of sulfonic esters |
| 12/20/2006 | CN1882536A 3-aminopyrrolidone derivatives |
| 12/20/2006 | CN1882534A Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 12/14/2006 | US20060281731 3,4,5-trihydroxy-2-methoxy-8,8-dimethyl-non-enoic acid ((3S,6S)-6-azido-2-oxo-azepan-3-yl)-amide; less toxicity, better selectivity in killing cancer cells, minimal effect on normal healthy cells |
| 12/13/2006 | EP1731505A1 Alkoxyphenylpropanoic acid derivatives |
| 12/13/2006 | EP1730114A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders |
| 12/13/2006 | EP1729737A1 Disintegrating tablets comprising licarbazepine |
| 12/12/2006 | US7148221 Vanilloid receptor ligands and their use in treatments |
| 12/12/2006 | US7147757 Method for separating an azepine derivative out of a mixture containing an amine an azepine derivative |
| 12/06/2006 | CN1875005A Malonamide derivatives blocking the activtiy of gamma-secretase |
| 12/06/2006 | CN1875004A Resolution of a narwedine amide derivative |
| 11/30/2006 | WO2006125622A1 Crystalline form of benzazepinium maleate derivative |
| 11/30/2006 | US20060270847 Process for producing nitrogenous heterocyclic compound |
| 11/30/2006 | CA2609489A1 Crystalline form of benzazepinium maleate derivative |
| 11/29/2006 | EP1725517A2 Process for the preparation of fenoldopam mesylate |
| 11/29/2006 | EP1725241A1 M3 muscarinic acetylcholine receptor antagonists |
| 11/29/2006 | EP1725240A1 Muscarinic acetylcholine receptor antagonists |
| 11/29/2006 | EP1496051B1 Method for preparing 6-aminomethyl-6,11-dihydro-5h-dibenz(b,e)azepine |
| 11/29/2006 | CN1871217A Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer |
| 11/29/2006 | CN1871013A Benzazepine derivatives as MAO-B inhibitors |
| 11/29/2006 | CN1286817C Process for the preparation of benazepril hydrochloride |